
@Manual{trialr,
    title = {trialr: Clinical Trial Designs in 'rstan'},
    author = {Kristian Brock},
    year = {2020},
    note = {R package version 0.1.5},
    url = {https://CRAN.R-project.org/package=trialr},
  }

@ARTICLE{Brock2019,
       author = {{Brock}, Kristian},
        title = "{trialr: Bayesian Clinical Trial Designs in R and Stan}",
      journal = {arXiv e-prints},
     keywords = {Statistics - Computation, Statistics - Applications, Statistics - Methodology, 97K80},
         year = "2019",
        month = "Jun",
          eid = {arXiv:1907.00161},
        pages = {arXiv:1907.00161},
archivePrefix = {arXiv},
       eprint = {1907.00161},
 primaryClass = {stat.CO},
       adsurl = {https://ui.adsabs.harvard.edu/abs/2019arXiv190700161B},
      adsnote = {Provided by the SAO/NASA Astrophysics Data System}
}

@article{OQuigley1990,
  title = {Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer.},
  volume = {46},
  issn = {0006-341X},
  doi = {10.2307/2531628},
  number = {1},
  journal = {Biometrics},
  author = {O'Quigley, J and Pepe, M and Fisher, L},
  year = {1990},
  keywords = {DoseFinding,CRM,Anti3+3},
  pages = {33-48}
}

@article{Thall2004,
  title = {Dose-{{Finding Based}} on {{Efficacy}}-{{Toxicity Trade}}-{{Offs}}},
  volume = {60},
  number = {3},
  journal = {Biometrics},
  author = {Thall, PF and Cook, JD},
  year = {2004},
  keywords = {adaptive design,phase ii,DoseFinding,EfficacyToxicity,dose-finding,bayesian design,biologic agents,phase i clinical trial},
  pages = {684-693},
  file = {/Users/k/Zotero/storage/EUBUF8QW/Thall, Cook - 2004 - Dose-Finding Based on Efficacy-Toxicity Trade-Offs.pdf;/Users/k/Zotero/storage/S84SNZVB/Thall, Cook - 2004 - Dose-Finding Based on Efficacy-Toxicity Trade-Offs.pdf}
}

@article{Thall2006,
  title = {Adaptive Dose Selection Using Efficacy-Toxicity Trade-Offs: Illustrations and Practical Considerations.},
  volume = {16},
  issn = {1054-3406},
  doi = {10.1080/10543400600860394},
  number = {5},
  journal = {Journal of biopharmaceutical statistics},
  author = {Thall, PF and Cook, JD and Estey, EH},
  year = {2006},
  keywords = {DoseFinding,EfficacyToxicity},
  pages = {623-638},
  pmid = {17037262}
}

@Manual{escalation,
    title = {escalation: Modular Approach to Dose Finding Clinical Trials},
    author = {Kristian Brock},
    year = {2020},
    note = {R package version 0.1.4},
    url = {https://CRAN.R-project.org/package=escalation},
  }

@Manual{dfcrm,
    title = {dfcrm: Dose-finding by the continual reassessment method},
    author = {Ken Cheung},
    year = {2013},
    note = {R package version 0.2-2},
    url = {https://CRAN.R-project.org/package=dfcrm},
}


@Manual{BOIN,
    title = {BOIN: Bayesian Optimal INterval (BOIN) Design for Single-Agent and
Drug- Combination Phase I Clinical Trials},
    author = {Ying Yuan and Suyu Liu},
    year = {2018},
    note = {R package version 2.6.4},
    url = {https://CRAN.R-project.org/package=BOIN},
}

@article{Neuenschwander2008,
  author = {Neuenschwander, Beat and Branson, Michael and Gsponer, Thomas},
  doi = {10.1002/sim.3230},
  journal = {Statistics in Medicine},
  keywords = {continual reassessment method,logistic model,maximum-tolerated dose},
  pages = {2420--2439},
  title = {{Critical aspects of the Bayesian approach to phase I cancer trials}},
  volume = {27},
  year = {2008}
}


